Disease stage, but not sex, predicts depression and psychological distress in Huntington's disease: A European population study

Journal of Psychosomatic Research

Volumn 80, Issue , 2016, Pages 17-22

  Dale, Maria ^a   Maltby, John ^a   Shimozaki, Steve ^a   Cramp, Rebecca ^a   Rickards, Hugh ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Anxiety; Depression; Disease stage; HADS; Huntington disease; Sex

Indexed keywords

ADULT; ANXIETY; ARTICLE; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE COURSE; DISTRESS SYNDROME; EUROPEAN; FEMALE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTIVE VALUE; SEX DIFFERENCE; SYMPTOMATOLOGY; TREND STUDY; AFFECT; AGED; COMPLICATION; EUROPE; HUNTINGTON DISEASE; MENTAL STRESS; MIDDLE AGED; POPULATION; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REGISTER; SEXUAL DEVELOPMENT; VERY ELDERLY; YOUNG ADULT;

ADULT; AFFECT; AGED; AGED, 80 AND OVER; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; DISEASE PROGRESSION; EUROPE; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; POPULATION; PSYCHIATRIC STATUS RATING SCALES; REGISTRIES; SEX CHARACTERISTICS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84951804793     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2015.11.003     Document Type: Article

References (51)

1. Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
2. Trottier Y., Biancalana V., Mandel J.L. Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J. Med. Genet. 1994, 31:377-382.
3. M. Dale, E. van Duijn, Anxiety in Huntington's disease. J. Neuropsychiatr. Clin. Neurosci. Published online first: 24 March 2015, doi:10.1176/appi.neuropsych.14100265.
4. Julien C.L., Thompson J.C., Wild S., et al. Psychiatric disorders in preclinical Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:939-943.
5. van Duijn E., Kingma E.M., van der Mast R.C. Psychopathology in verified Huntington's disease gene carriers. J. Neuropsychiatr. Clin. Neurosci. 2007, 19:441-448.
6. Slaughter J.R., Martens M.P., Slaughter K.A. Depression and Huntington's disease: prevalence, clinical manifestations, etiology, and treatment. CNS Spectr. 2001, 6:306-326.
7. Shiwach S., Norbury C.G. A controlled psychiatric study of individuals at risk for Huntington's disease. Br. J. Psychiatry 1994, 165:500-505.
8. Epping E.A., Mills J.A., Beglinger L.J., et al. Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. J. Psychiatr. Res. 2013, 47:1423-1431.
9. van Duijn E., Craufurd D., Hubers A.A.M., et al. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). J. Neurol. Neurosurg. Psychiatry 2014, 85:1411-1418.
10. Huntington Study Group United Huntington's Disease Rating Scale: reliability and consistency. Mov. Disord. 1996, 11:36-42.
11. Shoulson I., Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979, 29:1-3.
12. Thompson J.C., Harris J., Sollom A.C., et al. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. J. Neuropsychiatr. Clin. Neurosci. 2012, 24:53-60.
13. Kingma M., van Duijn E., Timman R., et al. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. Gen. Hosp. Psychiatry 2008, 30:155-161.
14. Paulsen S., Nehl C., Hoth K.F., et al. Depression and stages of Huntington's disease. J. Neuropsychiatr. Clin. Neurosci. 2005, 17:496-502.
15. Kessler R.C., McGonagle K.A., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51:8-19.
16. Patel V. Gender in Mental Health Research 2004, World Health Organization, Geneva, Switzerland.
17. Astbury J. Gender Disparities in Mental Health. Mental Health. Ministerial Round Tables 54th World Health Assembly 2001, World Health Organization, Geneva, Switzerland.
18. Zielonka D., Marinus J., Roos R.A.C., et al. The influence of gender on phenotype and disease progression in patients with Huntington's disease. Parkinsonism Relat. Disord. 2013, 19:192-197.
19. Pla P., Orvoen S., Saudou F., et al. Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms. Front. Behav. Neurosci. 2014, 8:135.
20. Orvoen S., Pla P., Gardier A.M., et al. Huntington's disease knock-in male mice show specific anxiety-like behavior and altered neuronal maturation. Neurosci. Lett. 2012, 507:127-132.
21. Pla P., Orvoen S., Benstaali C., et al. Huntingtin acts non cell-autonomously on hippocampal neurogenesis and controls anxiety-related behaviors in adult mouse. PLoS One 2013, 10.1371/journal.pone.0073902.
22. Grote H.E., Bull N.D., Howard M.L., et al. Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur. J. Neurosci. 2005, 22:2081-2088.
23. Renoir T., Zajac M.S., Du X., et al. Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression. PLoS One 2011, 10.1371/journal.pone.0022133.
24. Pang T.Y., Du X., Zajac M.S., et al. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. Hum. Mol. Genet. 2009, 18:753-766.
25. Hankin B.L. Development of sex differences in depressive and co-occurring anxious symptoms during adolescence: descriptive trajectories and potential explanations in a multi-wave prospective study. J. Clin. Child Adolesc. Psychol. 2009, 38:460-472.
26. Loutzenhiser L., McAuslan P., Sharpe D.P. The trajectory of maternal and paternal fatigue and factors associated with fatigue across the transition to parenthood. Clin. Psychol. 2015, 19:15-27.
27. Kessler E.M., Agines S., Bowen C.E. Attitudes towards seeking mental health services among older adults: personal and contextual correlates. Aging Ment. Health 2014, 19:182-191.
28. Di Marco F., Verga M., Reggente M., et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir. Med. CME 2006, 100:1767-1774.
29. Vodermaier A., Linden W., MacKenzie R., et al. Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br. J. Cancer 2011, 105:1814-1817.
30. van der Hoek T.C., Bus B.A., Matui P., et al. Prevalence of depression in Parkinson's disease: effects of disease stage, motor subtype and gender. J. Neurol. Sci. 2011, 310:220-224.
31. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983, 67:361-370.
32. Nance M.A., Ludowese C.J. Diagnosis of Huntington disease: model for a predictive testing program based on understanding the stages of psychological response. Am. J. Med. Genet. 1994, 52:118-120.
33. Bjelland I., Dahl A.A., Haug T.T., et al. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J. Psychosom. Res. 2002, 52:69-77.
34. De Souza J., Jones L.A., Rickards H. Validation of self-report depression rating scales in Huntington's disease. Mov. Disord. 2010, 25:91-96.
35. Mezuk B., Eaton W.W., Golden S.H., et al. The influence of educational attainment on depression and risk of type 2 diabetes. Am. J. Public Health 2008, 98:1480-1485.
36. Frank S. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators. BMC Neurol. 2009, 9:62.
37. Kushner M.G., Abrams K., Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin. Psychol. Rev. 2000, 20:149-171.
38. Hamalainen J., Kaprio J., Isometsa E., et al. Cigarette smoking, alcohol intoxication and major depressive episode in a representative population sample. J. Epidemiol. Community Health 2001, 55:573-576.
39. Picciotto M.R., Brunzell D.H., Caldarone B.J. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 2002, 13:1097-1106.
40. Aiken L., West S. Multiple Regression: Testing and Interpreting Interactions 1991, Sage, Newbury Park, CA.
41. Iani L., Lauriola M., Costantini M. A confirmatory bifactor analysis of the Hospital Anxiety and Depression Scale in an Italian community sample. Health Qual. Life Outcomes 2014, 12:84.
42. Cohen J. The concepts of power analysis. Statistical Power Analysis for the Behavioral Sciences 1998, 1-17. Academic Press, Inc., Hillsdale, New Jersey. J. Cohen (Ed.).
43. Beal C., Stuifbergen A.K., Sands D.V., et al. Depression in multiple sclerosis: a longitudinal analysis. Arch. Psychiatr. Nurs. 2007, 21:181-191.
44. Aziz N.A., Pijl H., Frölich M., et al. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease. J. Clin. Endocrinol. Metab. 2009, 94:1223-1228.
45. Shirbin C.A., Chua P., Churchyard A., et al. Cortisol and depression in pre-diagnosed and early stage Huntington's disease. Psychoneuroendocrinology 2013, 38:2439-2447.
46. Hubers A.A., van der Mast R.C., Pereira A.M., et al. Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease and its association with depressive symptoms and suicidality. J. Neuroendocrinol. 2015, 27:234-244.
47. Du X., Leang L., Mustafa T., et al. Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease. Translat. Psychiatry 2012, 2.
48. Kudielkaa B.M., Kirschbaumb C. Sex differences in HPA axis responses to stress: a review. Biol. Psychol. 2005, 69:113-132.
49. Rowe K.C., Paulsen J.S., Langbehn D.R., et al. Patterns of serotonergic antidepressant usage in prodromal Huntington disease. Psychiatry Res. 2012, 196:309-314.
50. Jaeschke R., Singer J., Guyatt G.H. Ascertaining the minimal clinically important difference. Control. Clin. Trials 1989, 10:407-415.
51. van Duijn E., Giltay E.J., Zitman F.G., et al. Measurement of psychopathology in Huntington's disease: the critical role of caregivers. J. Nerv. Ment. Dis. 2010, 198:329-333.